Cargando…
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Thyroid cancer incidence is increasing at an alarming rate, almost tripling every decade. In 2017, it was the fifth most common cancer in women. Although the majority of thyroid tumors are curable, about 2–3% of thyroid cancers are refractory to standard treatments. These undifferentiated, highly ag...
Autores principales: | Saini, Shikha, Tulla, Kiara, Maker, Ajay V., Burman, Kenneth D., Prabhakar, Bellur S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198524/ https://www.ncbi.nlm.nih.gov/pubmed/30352606 http://dx.doi.org/10.1186/s12943-018-0903-0 |
Ejemplares similares
-
Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer
por: Saini, Shikha, et al.
Publicado: (2019) -
Salutary Response to Targeted Therapy in Anaplastic Thyroid
Cancer
por: Fazeli, Sasan, et al.
Publicado: (2019) -
The Potential of Intralesional Rose Bengal to Stimulate T-Cell Mediated Anti-Tumor Responses
por: Maker, Ajay V, et al.
Publicado: (2015) -
Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases
por: Qin, Jian Zhong, et al.
Publicado: (2013) -
Identification of a Novel OX40L(+) Dendritic Cell Subset That Selectively Expands Regulatory T cells
por: Marinelarena, Alejandra, et al.
Publicado: (2018)